NCT02881658

Brief Summary

This is a local, single-center, two-arm, randomized, double-blind, placebo-controlled clinical trial that examines the LDL-C-lowering effect of the consumption of a soya beverage enriched with plant sterol for 3 weeks. This study also examines if there is other health-benefits by consuming the plant sterols fortified soya beverage in terms of serum total triglyceride, total and HDL cholesterol, other cardiometabolic risk factors and musculoskeletal-related traits including handgrip strength, gait speed, peak expiratory flow rate, bio-impedance and body balance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
201

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 29, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
8 months until next milestone

Results Posted

Study results publicly available

September 21, 2017

Completed
Last Updated

May 3, 2018

Status Verified

May 1, 2018

Enrollment Period

9 months

First QC Date

August 14, 2016

Results QC Date

May 20, 2017

Last Update Submit

May 2, 2018

Conditions

Keywords

Plant sterolsLow-Density Lipoprotein CholesterolPhytosterolsSoya Beverage

Outcome Measures

Primary Outcomes (1)

  • Mean of Serum Low-density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3

    From baseline to week 3

Secondary Outcomes (14)

  • Change of Low Density Lipoprotein Cholesterol (LDL-C) Via Blood Test at Baseline and Week 3

    From baseline to week 3

  • Change of High-density Lipoprotein Cholesterol (HDL-C) Via Blood Test at Baseline and Week 3

    From baseline to week 3

  • Change of Total Cholesterol Via Blood Test at Baseline and Week 3

    From baseline to week 3

  • Change of Triglycerides (TAG) Via Blood Test at Baseline and Week 3

    From baseline to week 3

  • Change of Serum Creatinine Via Blood Test at Baseline and Week 3

    From baseline to week 3

  • +9 more secondary outcomes

Study Arms (2)

Plant sterols-enriched soya beverage provided by Vitasoy

EXPERIMENTAL

Daily consumption of 2g of plant sterols as provided by one pack of 250 ml of plant sterols-enriched soya beverage for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).

Dietary Supplement: Plant sterols-enriched soya beverage provided by Vitasoy

Soya beverage provided by Vitasoy

PLACEBO COMPARATOR

Daily consumption of one pack of 250 ml of soya beverage (without plant sterols) for consecutive 3 weeks, each pack consumed once with main meal (i.e breakfast, lunch or dinner).

Dietary Supplement: Soya beverage provided by Vitasoy

Interventions

the study product is a 2g plant sterols-enriched in 250ml soya beverage

Plant sterols-enriched soya beverage provided by Vitasoy

the placebo product is a 250 ml soya beverage

Soya beverage provided by Vitasoy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Southern Chinese male or female ≥ 18 years;
  • In good general health as evidenced by medical history;
  • Have the ability to understand the requirements of the study, provide written informed consent, including consent for the use and disclose of research-related health information, and comply with the study data collection procedures. Provide signed and dated informed consent form

You may not qualify if:

  • Subject with familial hypercholesterolemia;
  • On regular medication(s) which affect gastrointestinal functions and blood lipids level for the past 3 months, such as, but not limited to:
  • Antibiotics of \>1 week duration
  • GI related medications such as antacids
  • Having blood lipid lowering medications such as statins, selective cholesterol absorption inhibitors (e.g. ezetimibe), fibrates, niacin, resins, omega- 3
  • Heavy-smokers (more than 1 pack per day)
  • Subject with heavy alcohol intake (\>40 g/day for men ; \>30 g/day for women) (32), or having history of alcohol abuse within 12 months prior to the study
  • Subjects with taste aversion to placebo/intervention soya beverages
  • Subject refusing to stop the consumption of plant sterols-enriched products if any during the study (other than the studied product) or having regular consumption of sterols/stanols cholesterol-lowering supplements/functional foods or other related products such as:
  • Sterol/ Stanol - containing margarines, milk, yoghurt drink and soya beverages
  • Sterol / Stanol supplements
  • Fish oils \& omega-3 supplements
  • Subject receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters
  • Pregnancy or lactation
  • Having soy allergy
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam

Hong Kong, Hong Kong

Location

Related Publications (1)

  • Chau YP, Cheng YC, Sing CW, Tsoi MF, Cheng VK, Lee GK, Cheung CL, Cheung BMY. The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial. Eur J Nutr. 2020 Sep;59(6):2739-2746. doi: 10.1007/s00394-019-02119-w. Epub 2019 Oct 23.

MeSH Terms

Conditions

Dyslipidemias

Condition Hierarchy (Ancestors)

Lipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Results Point of Contact

Title
Dr Cheung Ching Lung
Organization
The University of Hong Kong

Study Officials

  • Bernard Man Yung Cheung

    Li Ka Shing Faculty of Medicine, The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Department of Medicine, HKU

Study Record Dates

First Submitted

August 14, 2016

First Posted

August 29, 2016

Study Start

May 1, 2016

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

May 3, 2018

Results First Posted

September 21, 2017

Record last verified: 2018-05

Locations